← Back to Search

ESP Block for Spinal Surgery

N/A
Recruiting
Research Sponsored by Hospital for Special Surgery, New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours postoperatively
Awards & highlights

Study Summary

This trial will compare two methods of pain relief for lumbar spine surgery patients: a nerve block or no block. Results will help guide treatment decisions.

Who is the study for?
This trial is for adults aged 18-80 who are scheduled to undergo minimally invasive surgery for spinal stenosis. Participants should be in a stable health condition, classified as ASA 1, 2, or 3 by anesthesiologists.Check my eligibility
What is being tested?
The study is testing the effectiveness of the Erector Spinae Plane (ESP) block compared to no ESP block in patients having minimally invasive spine surgery. It's a randomized controlled trial which means participants will be randomly assigned to one of the two groups.See study design
What are the potential side effects?
Potential side effects from the ESP block may include discomfort at injection site, infection risk, and possible nerve damage; however specific side effects will depend on individual patient reactions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours postoperatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours postoperatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
24-hour oral morphine milligram equivalents (OMEs)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ESP BlockExperimental Treatment1 Intervention
Patients assigned to the "ESP Block" arm will receive an ESP block prior to the surgery.
Group II: ControlActive Control1 Intervention
Patients assigned to the "Control" group will not receive an ESP block prior to the surgery.

Find a Location

Who is running the clinical trial?

Hospital for Special Surgery, New YorkLead Sponsor
243 Previous Clinical Trials
59,282 Total Patients Enrolled

Media Library

ESP Block Clinical Trial Eligibility Overview. Trial Name: NCT05856539 — N/A
Minimally Invasive Transforaminal Lumbar Interbody Fusion Research Study Groups: Control, ESP Block
Minimally Invasive Transforaminal Lumbar Interbody Fusion Clinical Trial 2023: ESP Block Highlights & Side Effects. Trial Name: NCT05856539 — N/A
ESP Block 2023 Treatment Timeline for Medical Study. Trial Name: NCT05856539 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the research project admit individuals who are octogenarians?

"To be eligible for this medical trial, applicants must be between the ages of 18 and 80. Additionally, there is an additional 1 study available to those under the age of 18, as well as 75 trials accessible to people over 65."

Answered by AI

Who meets the eligibility requirements to partake in this experiment?

"This clinical trial requires enrollees to possess a history of minimally invasive transforaminal lumbar interbody fusion and be aged between 18 - 80. Approximately 48 individuals are eligible for inclusion in the study."

Answered by AI

Is enrollment for this clinical investigation currently open?

"This clinical trial, which was first listed on July 15th 2023 is no longer recruiting patients. The last update to the study happened on May 4th of this year and thus it has ceased recruitment activities. However, at present there are 75 other medical experiments actively seeking participants."

Answered by AI
Recent research and studies
~32 spots leftby Jul 2026